Premier Path Wealth Partners
BSX icon

Premier Path Wealth Partners’s Boston Scientific BSX Stock Holding History

Premier Path Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-5,044
Closed -$215K – 385
2026
Q2 		$215K Sell
5,044
-4,070
-45% -$221K 0.02% 390
2026
Q1 		$572K Buy
9,114
+378
+4% +$30.2K 0.07% 243
2025
Q4 		$833K Sell
8,736
-381
-4% -$37.4K 0.11% 178
2025
Q3 		$890K Buy
9,117
+344
+4% +$35.6K 0.11% 187
2025
Q2 		$942K Buy
8,773
+73
+0.8% +$7.39K 0.13% 177
2025
Q1 		$878K Buy
8,700
+9
+0.1% +$906 0.14% 175
2024
Q4 		$776K Buy
8,691
+6
+0.1% +$528 0.12% 180
2024
Q3 		$728K Sell
8,685
-34
-0.4% -$2.68K 0.11% 185
2024
Q2 		$671K Buy
8,719
+6
+0.1% +$439 0.11% 183
2024
Q1 		$597K Sell
8,713
-485
-5% -$31.2K 0.11% 179
2023
Q4 		$514K Buy
+9,198
New +$491K 0.11% 186

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Alecta Tjanstepension Omsesidigt
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Premier Path Wealth Partners's BSX Position: Q3 2026 in Review

Premier Path Wealth Partners sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 5,044 shares — an estimated $215K sold.

Premier Path Wealth Partners first reported a position in BSX in Q4 2023 and held it in 11 quarters. The position peaked at $942K in Q2 2025. 664 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Premier Path Wealth Partners reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • Premier Path Wealth Partners sold 5,044 Boston Scientific shares in Q3 2026, an estimated $215K.
  • Premier Path Wealth Partners first reported a position in Boston Scientific in Q4 2023 and held it in 11 quarters.
  • Premier Path Wealth Partners's Boston Scientific position peaked at $942K in Q2 2025.
  • 664 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.